Innovating Healthcare
Through Metapherine

Discover groundbreaking pharmaceutical solutions that transform lives. Our unicorn-inspired approach brings magic to medicine.

Pharmaceutical Research
Innovating Since 2015

About Metapherine

We are a visionary pharmaceutical company dedicated to developing transformative therapies that address unmet medical needs with our unique approach.

Our Facility
50+ Patents

Our Vision

At Metapherine, we believe in the power of imagination to heal. Like the mythical unicorn, we pursue what others deem impossible, creating pharmaceutical solutions that transcend conventional boundaries.

Cutting-Edge Research

Our team of 200+ scientists work tirelessly to develop novel compounds and delivery mechanisms.

Patient-Centric Approach

Every innovation is designed with the patient experience at its core, ensuring better outcomes and quality of life.

Global Impact

With operations in 15 countries, we're bringing our revolutionary treatments to patients worldwide.

Our Products

Discover our portfolio of innovative pharmaceutical products designed to address diverse therapeutic areas.

Neurophine

A breakthrough in neurological disorders, improving cognitive function and synaptic plasticity.

FDA Approved

CardioVex

Revolutionary cardiovascular treatment that enhances myocardial function and reduces risk factors.

Phase III Trials

GenoMend

Precision gene therapy targeting rare genetic disorders with unprecedented efficacy.

Breakthrough Therapy

Research & Development

Our commitment to innovation drives us to explore new frontiers in pharmaceutical science.

Our Approach

Metapherine's R&D strategy combines cutting-edge technology with unconventional thinking to develop therapies that redefine treatment paradigms.

Advanced Discovery

Utilizing AI-driven molecular modeling and high-throughput screening.

Precision Formulation

Developing targeted delivery systems for optimal therapeutic effect.

Clinical Excellence

Rigorous trials designed to demonstrate safety and efficacy.

Current Focus Areas

Neurodegenerative Diseases

Developing disease-modifying therapies for Alzheimer's, Parkinson's, and ALS.

Gene Therapy

CRISPR-based treatments for monogenic disorders.

Microbiome Therapeutics

Harnessing the gut-brain axis for metabolic and mental health.

Regenerative Medicine

Stem cell therapies for tissue repair and organ regeneration.

15+
Therapeutic Areas
50+
Clinical Trials
200+
Research Scientists
1M+
Patients Benefited

Contact Us

Get in touch with our team to learn more about our products, research collaborations, or career opportunities.

Our Locations

Global Headquarters

250 Innovation Drive, BioTech Park, San Francisco, CA 94107, USA

European Research Center

Science Park 300, 1098 XH Amsterdam, Netherlands

Asia-Pacific Hub

3 Science Park Drive, Singapore 118223

Connect With Us

Made with DeepSite LogoDeepSite - 🧬 Remix